We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

The COVID-19 Pandemic – Products

Carterra to Provide Antibody Screening and Characterization for the Coronavirus Immunotherapy Consortium (CoVIC) content piece image
Product News

Carterra to Provide Antibody Screening and Characterization for the Coronavirus Immunotherapy Consortium (CoVIC)

Carterra® Inc. and La Jolla Institute for Immunology (LJI) have announced that they will use Carterra’s proprietary LSA™ platform to screen hundreds of antibodies in just a few days.

Developing a COVID-19 Vaccine: Cobra Biologics Part of ChAdOx1 Consortium content piece image
Product News

Developing a COVID-19 Vaccine: Cobra Biologics Part of ChAdOx1 Consortium

Cobra Biologics has announced it is working as part of a consortium led by the Jenner Institute, Oxford University to rapidly develop, scale-up and produce the potential adenoviral vaccine candidate, ChAdOx1 nCov-19 (ChAdOx1), for fast-tracked clinical trials for COVID-19.
OPENCORONA Consortium: Collaborating to Develop a COVID-19 Vaccine content piece image
Product News

OPENCORONA Consortium: Collaborating to Develop a COVID-19 Vaccine

Cobra and the Karolinska Institutet have been awarded €3 million emergency funding by Horizon 2020 for research and development, and phase I clinical trial testing of a DNA vaccine against COVID-19, as part of the OPENCORONA consortium.
Streamlining Immune System Data Management and Analysis content piece image
Product News

Streamlining Immune System Data Management and Analysis

ENPICOM has announced a major release of its ImmunoGenomiX (IGX) Platform, designed to streamline the analysis and management of vast amounts of repertoire sequencing data, accelerating the discovery and development of new biological targets.
Luminex Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Panel content piece image
Product News

Luminex Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Panel

Luminex Corporation has announced that the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its NxTAG® CoV Extended Panel.
Sorrento and SmartPharm To Collaborate in Development of Novel Gene-encoded Antibody Vaccine Against COVID-19 content piece image
Product News

Sorrento and SmartPharm To Collaborate in Development of Novel Gene-encoded Antibody Vaccine Against COVID-19

In response to the government call for rapidly deployable countermeasures, Sorrento Therapeutics, Inc. (Nasdaq: SRNE, Sorrento) and SmartPharm Therapeutics Inc. (SmartPharm) announced a research and development collaboration to develop a next-generation, gene-encoded antibody vaccine for COVID-19.
Reagents for Serological Assay of SARS-CoV-2 content piece image
Product
Advertisement

Reagents for Serological Assay of SARS-CoV-2

Point-of-Care Test Can Detect COVID-19 in As Little as 5 Minutes content piece image
Product News

Point-of-Care Test Can Detect COVID-19 in As Little as 5 Minutes

FDA grants emergency use authorization for fastest available molecular point-of-care test for novel coronavirus.
N4 Pharma Exploring How Nuvec® Can Be Used To Help Fight COVID-19 content piece image
Product News

N4 Pharma Exploring How Nuvec® Can Be Used To Help Fight COVID-19

N4 Pharma has announced that it will be undertaking a proof of concept research project using a COVID-19 DNA plasmid for the purpose of demonstrating the ability of Nuvec® to be used as a delivery system by potential collaboration partners developing COVID-19 DNA or RNA vaccines.
Antibody-based COVID-19 Diagnostic Test Receives CE Mark content piece image
Product News

Antibody-based COVID-19 Diagnostic Test Receives CE Mark

The Anti-SARS-CoV-2 ELISAs for immunoglobulin classes A and G from EUROIMMUN, a PerkinElmer, Inc. company, have received the CE mark and can now be applied to COVID-19 diagnostics.
Advertisement